By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AstraZeneca PLC 

15 Stanhope Gate

London  England  W1K 1LN  United Kingdom
Phone: 44-20-7304-5000 Fax: 44-20-7304-5151


AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology. The company is also active in inflammation, infection and neuroscience through numerous collaborations. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.




CEO: Pascal Soriot

CFO: Marc Dunoyer

CMO: Marc Dunoyer

CTO: Andrew Chen

CCO: Katarina Ageborg

CMO: Sean Bohen


Please click here for clinical trial information.


Please click here for AstraZeneca job opportunities.


AstraZeneca Medications

For more information, visit and follow us on


Key Statistics

Ownership: Public

Web Site: AstraZeneca PLC
Employees: 50,000 worldwide
Symbol: AZN

Company News
AstraZeneca PLC (AZN) Consolidating 350 California Jobs to the Bay Area 9/28/2016 5:59:47 AM
AstraZeneca PLC (AZN) Yanks Ovarian Cancer EU Application After 'Differences Of Opinion' With Regulators 9/22/2016 7:38:57 AM
AstraZeneca PLC (AZN) to Shutter Pennsylvania Office, 134 Employees Affected 9/22/2016 6:33:00 AM
AstraZeneca PLC (AZN) Selects LLamasoft As Supply Chain Design Partner Of Choice 9/21/2016 11:29:19 AM
AstraZeneca PLC (AZN) Release: Phase III Combination Trial Of BYDUREON And FARXIGA Shows Significant Blood Sugar Reduction In Patients With Type 2 Diabetes 9/16/2016 10:57:29 AM
Redx Pharma CFO to Step Down Just as Former AstraZeneca PLC (AZN) Exec Joins Roster 9/8/2016 6:03:22 AM
Allena Pharma Taps AstraZeneca PLC (AZN) Exec as New CFO 9/7/2016 5:59:53 AM
AstraZeneca PLC (AZN)'s Asthma Candidate Does Well in Final Late-Stage Test 9/6/2016 6:05:36 AM
MRC Technology, AstraZeneca PLC (AZN), Asthma UK And British Lung Foundation Enter Into Collaboration To Explore Novel Treatments For Respiratory Diseases 9/1/2016 11:00:10 AM
AstraZeneca PLC (AZN)'s Long-Acting Asthma Drug Symbicort Safe in Two Trials 9/1/2016 6:41:23 AM